Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

109
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
109

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential role of Akkermansia massiliensis in multiple sclerosis protection by the FcRL3 gene.

Genes and immunity·2026
Same author

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.

The journal of headache and pain·2026
Same author

Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure development.

PloS one·2026
Same author

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort.

Drugs - real world outcomes·2026

Related Experiment Video

Updated: Jul 17, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Decision trees to evaluate the risk of developing multiple sclerosis.

Manuela Pasella1, Fabio Pisano1, Barbara Cannas1

  • 1Department of Electrical and Electronic Engineering, University of Cagliari, Cagliari, Italy.

Frontiers in Neuroinformatics
|August 31, 2023
PubMed
Summary

A new machine learning model uses immunogenetic markers to predict multiple sclerosis (MS) risk. This tool can help identify at-risk individuals and monitor family members of MS patients.

Keywords:
decision treeshuman leukocyte antigenimmunogenetic risk markerslikelihood of multiple sclerosis developmentmachine learningmultiple classifiermultiple sclerosis

More Related Videos

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Related Experiment Videos

Last Updated: Jul 17, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Area of Science:

  • Neurology
  • Immunogenetics
  • Machine Learning

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease affecting the central nervous system, with uncertain etiology attributed to genetic and environmental factors.
  • Current MS diagnosis involves clinical assessment, neuroimaging, and cerebrospinal fluid analysis, with no definitive cure available.

Purpose of the Study:

  • To develop a predictive machine learning tool for assessing the risk of developing multiple sclerosis.
  • To identify key immunogenetic risk markers associated with MS development.

Main Methods:

  • A decision tree-based machine learning algorithm was developed.
  • The algorithm integrated demographic factors (initially) and immunogenetic markers, including Human Leukocyte Antigen (HLA) class I alleles and Killer Immunoglobulin-like Receptor (KIR) genes.
  • Demographic factors were excluded due to bias, focusing solely on immunogenetic markers.

Main Results:

  • The study included 619 healthy controls and 299 MS patients from Sardinia.
  • Excluding gender, the algorithm achieved 73.24% accuracy in identifying MS patients and 66.07% in identifying healthy individuals.
  • The model demonstrated the predictive power of immunogenetic markers in MS risk assessment.

Conclusions:

  • The developed machine learning system shows potential for clinical application.
  • It can aid in monitoring relatives of MS patients and identifying at-risk individuals.
  • Further research may refine predictive capabilities for early MS detection and intervention.